Alfa study

More than 2,700 children of alzheimer’s disease sufferers prepared to change history

MORE THAN 2,700 CHILDREN OF ALZHEIMER’S DISEASE SUFFERERS PREPARED TO CHANGE HISTORY

We know that the damage that Alzheimer’s disease causes in the brain may have started silently up to 20 years before the first symptoms are revealed. We need to anticipate it, to study what happened in the brain years before the appearence of Alzheimer’s disease. Our aim is to act before it is too late and the damage is irreversible.

alfaestudi.org

José Luis Molinuevo, MD, PhD
“Every day we are closer to anticipating Alzheimer’s disease”

José Luis Molinuevo, MD, PhD

Neurologist, Scientific Director of the Pasqual Maragall Foundation

The Alfa Study in figures

A part of the study a series of tests are performed on descendants of patients with Alzheimer’s disease who are given a set of tests every three years for a long period lasting decades, to see the risk factors and the biological indicators which might point to the development of Alzheimer’s disease.

Volunteer descendants of people with Alzheimer’s disease

2,734

Volunteer descendants of people with Alzheimer’s disease

Professionals

50

Professionals

Visiting-hours

9,891

Visiting-hours

Samples in the biobank

10,892

Samples in the biobank

Cognitive tests

78,963

Cognitive tests

MRI scans

421

MRI scans

THE VOLUNTEERS, THE SOUL OF THE ALFA STUDY

Cristina

“I will do what is necessary to help in the fight against Alzheimer’s disease. I want to prevent my children from enduring the same fate”

Cristina

Alfa Study Volunteer

Maria Antonia

“I want to help the research. For 10 years, I lived through my mother's disease and I want to do something”

Maria Antonia

Alfa Study Volunteer


Barcelonaßeta Brain Reserach Center SCIENTIFIC ADVISORY BOARD

Frederik Barkhof, MD, PhD

VU University Medical Centre, Amsterdam, The Netherlands / UCL institutes of Biomedical Engineering and Neurology, London, UK

Kaj Blennow, MD, PhD

Dept. of Clinical Neuroscience, University of Gothenburg, Sweden / Sahlgrenska University Hospital, Gothenburg, Sweden

Bruno Dubois, MD, PhD

University Salpêtrière Hospital, Paris, France / University Pierre & Marie Curie, Paris, France

Miia Kivipelto, MD, PhD

Karolinska Institutet, Stockholm, Sweden

John C. Morris, MD

Harvey A and Dorismae Hacker Friedman, Washington, USA / Washington University School of Medicine, St. Louis, USA

Reisa A. Sperling

Center for Alzheimer's Research and Treatment / Massachusetts Alzheimer's Disease Research Center / Harvard Medical School, Boston, USA.

A STRATEGIC COMMITMENT FROM “LA CAIXA” FOUNDATION

Jaume Lanaspa
“Research is one of our institution's priorities, to which we devote a large number of resources, but the volunteers and carergivers of a patient with Alzheimer’s disease are the true heroes of this adventure"

Jaume Lanaspa

Patron of the “La Caixa” Foundation

For a future without Alzheimer’s disease

Your donation will be used for scientific research to beat the disease.